Just prior to the start of the recent AAO Meeting in San Francisco, two venture capitalists sponsored a meeting to allow some early-stage and small ophthalmic companies to showcase their technologies to a room full of potential investors and ophthalmic industry leaders. The Ophthalmic Innovation Summit was the idea of Emmett Cunningham and Bill Link.

Over 400 attendees heard ten-minute presentations from twelve small  device companies and thirteen pharmaceutical companies, all developing innovative products aimed at ophthalmic diseases.

I have written up a full review of the meeting, listing the twenty five presenting companies, along with an interview of Dr. Cunningham speaking about the Summit and issues related to ophthalmic drug and device development.

Here is the link ^[1].